Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC)

NCT04930549 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Rouen

Collaborators